Liposits, G., Winther, S. B., Ryg, J.
, Skuladottir, H., Möller, S., Hofsli, E., Shah, C. H.
, Poulsen, L. Ø., Berglund, Å., Qvortrup, C., Osterlund, P., Glimelius, B., Sorbye, H. & Pfeiffer, P. (2024).
The effect of BRAFV600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer – A post-hoc exploratory analysis of the randomized NORDIC9-study.
Journal of Geriatric Oncology,
15(2), Article 101632.
https://doi.org/10.1016/j.jgo.2023.101632
Prager, G. W., Taieb, J., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez, E., Cruz, F. M., Wyrwicz, L., Stroyakovskiy, D., Pápai, Z., Poureau, P. G.
, Liposits, G., Cremolini, C., Bondarenko, I., Modest, D. P., Benhadji, K. A., Amellal, N., Leger, C., Vidot, L. & Tabernero, J. (2023).
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
New England Journal of Medicine,
388(18), 1657-1667.
https://doi.org/10.1056/NEJMoa2214963